Dermatological reactions to the multitargeted tyrosine kinase inhibitor sunitinib.

Background: The multikinase inhibitor sunitinib has enhanced the treatment of renal cell carcinoma and gastrointestinal stromal tumor through an improved clinical response with decreased systemic toxicities. However, sunitinib is frequently associated with dermatological adverse reactions. The physi...

Descripción completa

Detalles Bibliográficos

Publicado en:	Supportive Care in Cancer Vol. 16; no. 6; pp. 557 - 567
Autores principales:	Rosenbaum SE, Wu S, Newman MA, West DP, Kuzel T, Lacouture ME, Rosenbaum, S E, Wu, S, Newman, M A, West, D P, Kuzel, T, Lacouture, M E
Formato:	research Journal Article
Publicado:	Springer Nature Jun2008
Acceso en línea:	Ver este registro en EBSCOhost